Unknown

Dataset Information

Evaluation of Information Theoretic Network Meta-analysis to Rank First-Line Anticancer Regimens for Hormone Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer.


ABSTRACT:

Importance

Hormone receptor-positive, ERBB2 (formerly HER2/neu)-negative metastatic breast cancer (HR-positive, ERBB2-negative MBC) is treated with targeted therapy, endocrine therapy, chemotherapy, or combinations of these modalities; however, evaluating the increasing number of treatment options is challenging because few regimens have been directly compared in randomized clinical trials (RCTs), and evidence has evolved over decades. Information theoretic network meta-analysis (IT-NMA) is a graph theory-based approach for regimen ranking that takes effect sizes and temporality of evidence into account.

Objective

To examine the performance of an IT-NMA approach to rank HR-positive, ERBB2-negative MBC treatment regimens.

Data sources

HemOnc.org, a freely available med

SUBMITTER: Li X 

PROVIDER: S-EPMC9008500 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature